We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.

  • Guidelines Recommend Use of FES PET Imaging for Lobular Breast Cancer

    tim.hodson

    Fri, 05/30/2025 – 16:23

    May 30, 2025 — GE HealthCare recently announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for clinicians now recommend considering fluoroestradiol (FES) positron emission tomography (PET) for systemic staging in patients with recurrent or metastatic lobular breast cancer.
    GE HealthCare’s Cerianna (fluoroestradiol F18) injection, available in the United States, is the only FDA-approved imaging agent for the detection …

    Read the full article on itnonline.com

  • Hyperfine Receives FDA Clearance of Optive AI Software

    tim.hodson

    Thu, 05/29/2025 – 16:38

    Hyperfine, Inc., producer of the world’s first FDA-cleared AI-powered portable MRI system for the brain — the Swoop system — has announced FDA clearance of its next-generation software.
    This tenth-generation release delivers a substantial increase in image quality for ultra-low-field MR imaging. Optive AI software enhances each stage of the imaging process   — from noise cancellation and image acquisition to reconstruction and post-processing. The…

    Read the full article on itnonline.com

  • DeepLook Medical's Imaging Software Now in Commercial Use at Major Healthcare Institutions

    tim.hodson

    Wed, 05/28/2025 – 12:25

    May 27, 2025 — DeepLook Medical, a company advancing medical imaging through visual enhancement technology, recently announced that its flagship product, DL Precise, is now in commercial use at major healthcare institutions across the United States, including Cleveland Clinic, AdventHealth, Mayo Clinic, Geisinger and others.
    This marks the continuation of DeepLook’s commercial rollout, following successful pilots and initial data confirming the pl…

    Read the full article on itnonline.com

  • Philips' RADIQAL Study to Examine Ultra-Low X-ray Dose Technology in Coronary Procedures

    tim.hodson

    Tue, 05/27/2025 – 12:26

    May 20, 2025 — Royal Philips has launched  the RADIQAL (Radiation Dose and Image Quality Trial) trial. This multicenter, randomized study, sponsored by Philips will enroll 824 coronary artery disease patients across 6 hospitals in Spain, Czech Republic and the US. The first patient in the study was enrolled at Aarhus University Hospital, Denmark.
    “The ability to reduce radiation exposure without compromising procedural performance is a key priorit…

    Read the full article on itnonline.com

  • Intelerad, RADPAIR Partner to Enhance Radiology Reporting with AI

    tim.hodson

    Wed, 05/21/2025 – 16:10

    May 20, 2025 – Intelerad, a provider of medical imaging software solutions, recently announced its prime partnership with RADPAIR, a provider of generative AI-driven radiology solutions, to deliver an enhanced radiology reporting experience. This partnership combines Intelerad’s workflow orchestration capabilities with RADPAIR’s agentic AI technology allowing radiologists to work more efficiently by automating entire portions of reporting workflow…

    Read the full article on itnonline.com

  • Konica Minolta, NewVue Team Up to Launch Integrated Teleradiology Solution

    tim.hodson

    Wed, 05/21/2025 – 11:37

    May 21, 2025 — Konica Minolta Healthcare Americas, Inc and NewVue have announced the introduction of Exa Teleradiology, Powered by NewVue to meet the complex needs of modern teleradiology groups. Designed specifically for distributed reading environments, Exa Teleradiology will streamline the reading experience across multiple systems and facilities, including imaging centers, all delivered through a single cloud-based solution that leverages deep…

    Read the full article on itnonline.com

  • Ultrasound Enhancing Agent Receives Pediatric Indication Approval from FDA

    tim.hodson

    Tue, 05/20/2025 – 12:42

    May 13, 2025– GE HealthCare recently announced the U.S. Food and Drug Administration (FDA) has approved a pediatric indication for the company’s Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) ultrasound enhancing agent (UEA). This approval will help improve the clarity and diagnostic accuracy of echocardiograms in pediatric patients, giving cardiologists a fuller picture of ventricular function when assessing possible…

    Read the full article on itnonline.com

  • FDA Clearance Granted to Arineta’s Cardiac CT Scanner

    tim.hodson

    Mon, 05/19/2025 – 11:17

    May 19, 2025 – Arineta, a provider of cardiovascular imaging solutions, recently announced that its SpotLight Duo cardiac CT scanner has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for low-dose lung cancer screening (LDCT). This clearance allows providers to use a single ultra-fast CT platform for both cardiac and lung imaging and diagnostics, delivering more complete care to high-risk patients.
    Lung cancer is the le…

    Read the full article on itnonline.com

  • Bialogics Introduces Evidence-Driven Framework for AI Performance Monitoring

    tim.hodson

    Fri, 05/16/2025 – 16:30

    May 14, 2025 – Bialogics Analytics Inc., a leader in radiology informatics, has introduced its new AI solution AI Quality Framework (AIQ), a first-of-its-kind, evidence-driven framework for continuous, real-time assessment of AI systems in diagnostic imaging.
    Despite AI’s growing presence in radiology, lingering doubts about reliability, transparency, and real-world effectiveness are challenging widespread adoption. AIQ addresses these concerns he…

    Read the full article on itnonline.com

  • New Research: Texture Patterns Can Help Identify Breast Cancer Risk

    tim.hodson

    Fri, 05/16/2025 – 09:03

    May 13, 2025 — In one of the larger studies of its kind, researchers have identified six breast texture patterns that may be associated with increased cancer risk, according to a new study published in Radiology, a journal of the Radiological Society of North America (RSNA).
    Women with dense breasts, which are breasts with a higher proportion of glandular tissue compared to fatty tissue, make up a large proportion of screening-eligible women. Brea…

    Read the full article on itnonline.com